Talasaz AmirAli 4
4 · Guardant Health, Inc. · Filed Dec 10, 2025
Insider Transaction Report
Form 4
Talasaz AmirAli
DirectorCo-Chief Executive Officer
Transactions
- Other
Common Stock
2025-12-08−387,946→ 82,854 total(indirect: Shares held by Talasaz Investments, L.P.) - Other
Common Stock
2025-12-08+193,973→ 218,223 total(indirect: By Trust) - Sale
Common Stock
2025-12-08$104.21/sh−15,000$1,563,125→ 203,223 total(indirect: By Trust) - Sale
Common Stock
2025-12-08$105.34/sh−30,760$3,240,172→ 172,463 total(indirect: By Trust) - Sale
Common Stock
2025-12-08$106.00/sh−4,240$449,440→ 168,223 total(indirect: By Trust)
Footnotes (3)
- [F1]Reflects changes in form of ownership from Talasaz Investments LP due to the transfer of shares to The AmirAli Talasaz 2018 Children's Remainder Trust dated 9/25/2018, and Maryam Eskandari 2018 Children's Remainder Trust, dated 9/25/2018.
- [F2]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $104.00 to $104.75. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.81. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.